Month: May 2025

CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans  CNBC Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies  PR Newswire Eli Lilly shares fall as competitor Novo notches coverage win for … Read more

Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes are wafting across the Pharmalot campus, where the official mascots are foraging for their breakfast and rousing the neighbors. This means we are free to focus on the matters at hand — rummaging through our to-do list … Read more

Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm anticipates strong revenue growth, aiming for a 20% increase, while addressing side-effects and weight maintenance post-treatment.